Companies:
53,014
Total Market Cap:
170078293185789.96
Global Rank
#494
Country Rank
#10
Market Cap
50.86 B
Price
216.81
Change (%)
0.85%
Volume
244,715
Galderma Group AG's latest marketcap:
50.86 B
As of 07/08/2026, Galderma Group AG's market capitalization has reached $50.86 B. According to our data, Galderma Group AG is the 494th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 50.86 B |
| Revenue (ttm) | 5.15 B |
| Net Income (ttm) | 602.03 M |
| Shares Out | 234.57 M |
| EPS (ttm) | 2.53 |
| Forward PE | 47.78 |
| Ex-Dividend Date | 04/24/2026 |
| Earnings Date | 07/23/2026 |
Market Cap Chart
Data Updated: 07/08/2026
Galderma Group AG's yearly market capitalization.
Galderma Group AG has seen its market value grow from ₣23.91 B to ₣41.06 B since 2024, representing a total increase of 71.74% and an annual compound growth rate (CAGR) of 42.68%.
| Date | Market Cap(₣) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/08/2026 | ₣41.06 B | $50.86 B | 5.42% | 494 |
| 12/30/2025 | ₣38.48 B | $47.84 B | 60.96% | 643 |
| 12/30/2024 | ₣23.91 B | $26.33 B | 728 |
Company Profile
About Galderma Group AG
Galderma Group AG is a global leader in dermatology, offering a science-driven portfolio of products and services across multiple segments of the dermatology market.
Core Business Segments
- Injectable Aesthetics: Features flagship brands like Dysport/Azzalure, Alluzience, Restylane, and Sculptra.
- Dermatological Skincare: Includes renowned brands such as Cetaphil and Alastin.
- Therapeutic Dermatology: Covers treatments like Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl.
Founded in 1981, Galderma Group AG is headquartered in Zug, Switzerland.
Frequently Asked Questions
-
What is Galderma Group AG's (SWX-GALD) current market cap?As of 07/08/2026, Galderma Group AG (including the parent company, if applicable) has an estimated market capitalization of $50.86 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Galderma Group AG (SWX-GALD) rank globally by market cap?Galderma Group AG global market capitalization ranking is approximately 494 as of 07/08/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.